DNA Methylation Markers for Breast Cancer Detection in the Developing World.

CONCLUSIONS: We developed and piloted a fast, and accurate methylation marker-based automated cartridge system to detect breast cancer in FNA samples. This quick ancillary test has the potential to prioritize cancer over benign tissues for expedited pathologic evaluation in poorly resourced countries.
PMID: 31300453 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - July 11, 2019 Category: Cancer & Oncology Authors: Downs B, Mercado-Rodriguez C, Cimino-Mathews A, Chen C, Yuan J, Van Den Berg EJ, Cope L, Schmitt F, Tse GM, Ali SZ, Meir-Levi D, Sood R, Li J, Richardson AL, Mosunjac M, Rizzo M, Tulac S, Kocmond K, de Guzman TN, Lai EW, Rhees B, Bates M, Wolff AC, Gabrie Tags: Clin Cancer Res Source Type: research